Evidence map›Paper›PMID 29725262›Full record

ArticleInternational journal of biological sciences2018

Simvastatin Suppresses Proliferation and Migration in Non-small Cell Lung Cancer via Pyroptosis.

Fengjiao Wang, Wei Liu, Jinfeng Ning, Junfeng Wang, Yaoguo Lang, Xiangyuan Jin, Kaibin Zhu, Xiuyun Wang, Xiaoguang Li, Fan Yang and 2 more

Open access · goldAbstract read
In one paragraph

Article in International journal of biological sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 80 papers.

0numbers the graph read from it
0cells of the map it votes in
80citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

80 citing papers in PubMed, 131 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article

20 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Fengjiao WangDepartment of Thoracic Surgery, Harbin Medical University Cancer Hospital, Harbin, 150001, China.
Wei LiuThe Fourth Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, 150001, China.
Jinfeng NingDepartment of Thoracic Surgery, Harbin Medical University Cancer Hospital, Harbin, 150001, China.
Junfeng WangDepartment of Thoracic Surgery, Harbin Medical University Cancer Hospital, Harbin, 150001, China.
Yaoguo LangDepartment of Thoracic Surgery, Harbin Medical University Cancer Hospital, Harbin, 150001, China.
Xiangyuan JinDepartment of Thoracic Surgery, Harbin Medical University Cancer Hospital, Harbin, 150001, China.
Kaibin ZhuDepartment of Thoracic Surgery, Harbin Medical University Cancer Hospital, Harbin, 150001, China.
Xiuyun WangDepartment of Abdominal Ultrasound, First Hospital of Harbin Medical University, Harbin, 150001, China.
Xiaoguang LiDepartment of Cell Biology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Fan YangDepartment of Endocrinology, The Second Affiliated Hospital of Harbin Medical University, Harbin, 150001, China.
Jianqun MaDepartment of Thoracic Surgery, Harbin Medical University Cancer Hospital, Harbin, 150001, China.
Shidong XuDepartment of Thoracic Surgery, Harbin Medical University Cancer Hospital, Harbin, 150001, China.
Harbin Medical University · CNThird Affiliated Hospital of Harbin Medical University · CNJohns Hopkins University · USSecond Affiliated Hospital of Harbin Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pyroptosis is a form of caspase-1-dependent programmed cell death with anti-tumor properties, but the underlying molecular mechanisms are not fully understood. The results of our study showed that the antihyperlipidemic drug simvastatin induced pyroptosis in non-small cell lung cancer (NSCLC) cell lines and a xenograft mouse model. Inhibition of pyroptosis attenuated the effects of simvastatin on tumor cell viability and migration. These data suggest that simvastatin may induce pyroptosis, thereby potentially serving as a novel therapeutic agent for NSCLC.

Indexed as

AnimalsCarcinoma, Non-Small-Cell LungCell Line, TumorCell MovementCell ProliferationHumansLung NeoplasmsMicePyroptosisSimvastatinXenograft Model Antitumor AssaysSimvastatincancer therapycaspase-1NSCLCpyroptosisSimvastatin

Identifiers

PMID29725262
PMCPMC5930473
OpenAlexW2792875602

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.